Works matching IS 09725229 AND DT 2021 AND VI 25 AND IP 11

Results: 26
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11

    COVID-19 has become a major pandemic in recent times. The exact pathophysiology and understanding of cytokine storm and immunomodulation are evolving. Various cytokines have been implicated in the pathophysiology of COVID-19. Immunosuppressant immunomodulators like steroids, canakinumab, anakinra, tocilizumab, sarilumab, baricitinib, ruxolitinib, bevacizumab, and itolizumab have been tried. Immunostimulant immunomodulators like interferons (IFNs) and Mycobacterium w (Mw) have also been repurposed. Considering the role of multiple cytokines implicated in COVID-19, molecules working on the majority of the targets, may hold a promising future prospect.

    Published in:
    Indian Journal of Critical Care Medicine, 2021, v. 25, n. 11, p. 1288, doi. 10.5005/jp-journals-10071-24029
    By:
    • Rangappa, Pradeep
    Publication type:
    Article
    12
    13

    Expert Consensus Statements on the Use of Corticosteroids in Non-severe COVID-19.

    Published in:
    Indian Journal of Critical Care Medicine, 2021, v. 25, n. 11, p. 1280
    By:
    • Nasa, Prashant;
    • Chaudhry, Dhruva;
    • Govil, Deepak;
    • Daga, Mradul K.;
    • Jain, Ravi;
    • Chhallani, Akshaykumar A.;
    • Krishna, Apoorv;
    • Jagiasi, Bharat G.;
    • Juneja, Deven;
    • Barthakur, Himadri S.;
    • Jha, Hrishikesh;
    • Gurjar, Mohan;
    • Rangappa, Pradeep;
    • Aladakatti, Raghunath;
    • Mishra, Rajesh C.;
    • Shetty, Rajesh M.;
    • Yadav, Rohit;
    • Garg, Sandeep;
    • Nandakumar, Sivakumar M.;
    • Samavedam, Srinivas
    Publication type:
    Article
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26